Inactivation of TNFα in murine models of MPN or in primary patient cells resulted in reduced disease development in vivo and abrogated clonal growth ex vivo, indicating its functional importance as an effector of JAK2-V617F signaling. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.